Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
10.69
+0.61 (6.05%)
At close: Mar 31, 2026, 4:00 PM EDT
10.51
-0.18 (-1.68%)
After-hours: Mar 31, 2026, 7:36 PM EDT

Elicio Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Elicio Therapeutics stock have an average target of 17, which predicts a 59.03% increase from the current stock price of 10.69.

Price Target: $17 (+59.03%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$17$17$17$17
Change+59.03%+59.03%+59.03%+59.03%

Analyst Ratings

The average analyst rating for Elicio Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingOct '25Nov '25Dec '25Jan '26Feb '26Mar '26
Strong Buy222222
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$13$17
Strong BuyMaintains$13$17+59.03%Mar 13, 2026
Rodman & Renshaw
Rodman & Renshaw
Strong Buy
Initiates
$17
Strong BuyInitiates$17+59.03%Mar 10, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$10$13
Strong BuyMaintains$10$13+21.61%Jul 17, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong BuyReiterates$10-6.45%Apr 2, 2025
Jones Trading
Jones Trading
Strong Buy
Initiates
$9
Strong BuyInitiates$9-15.81%Oct 31, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.54
from -2.58
EPS Next Year
-1.43
from -1.54
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
-1.73-89.27-6.96-4.25-2.58-1.54-1.43
EPS Growth
-------
Forward PE
-------
No. Analysts
-----43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202620272028
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202620272028
High--
Avg--
Low--

EPS Forecast

EPS202620272028
High-1.35-1.47
Avg-1.54-1.43
Low-1.69-1.37

EPS Growth

EPS Growth202620272028
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.